title: The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine.
abstract: To identify genetic determinants of classical swine fever virus (CSFV) virulence and host range, chimeras of the highly pathogenic Brescia strain and the attenuated vaccine strain CS were constructed and evaluated for viral virulence in swine. Upon initial screening, only chimeras 138.8v and 337.14v, the only chimeras containing the E2 glycoprotein of CS, were attenuated in swine despite exhibiting unaltered growth characteristics in primary porcine macrophage cell cultures. Additional viral chimeras were constructed to confirm the role of E2 in virulence. Chimeric virus 319.1v, which contained only the CS E2 glycoprotein in the Brescia background, was markedly attenuated in pigs, exhibiting significantly decreased virus replication in tonsils, a transient viremia, limited generalization of infection, and decreased virus shedding. Chimeras encoding all Brescia structural proteins in a CS genetic background remained attenuated, indicating that additional mutations outside the structural region are important for CS vaccine virus attenuation. These results demonstrate that CS E2 alone is sufficient for attenuating Brescia, indicating a significant role for the CSFV E2 glycoprotein in swine virulence.
authors.affiliation: Plum Island Animal Disease Center, USDA/ARS/NAA, P.O. Box 848, Greenport, NY 11944-0848, USA.
authors.forename: G R
authors.initials: GR
authors.lastname: Risatti
authors.forename: M V
authors.initials: MV
authors.lastname: Borca
authors.forename: G F
authors.initials: GF
authors.lastname: Kutish
authors.forename: Z
authors.initials: Z
authors.lastname: Lu
authors.forename: L G
authors.initials: LG
authors.lastname: Holinka
authors.forename: R A
authors.initials: RA
authors.lastname: French
authors.forename: E R
authors.initials: ER
authors.lastname: Tulman
authors.forename: D L
authors.initials: DL
authors.lastname: Rock
mesh_terms: D000818:Animals; D001483:Base Sequence; D018929:Cell Culture Techniques; D006691:Classical Swine Fever / Q000473:pathology / Q000821:virology; D006692:Classical Swine Fever Virus / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D008969:Molecular Sequence Data; D014066:Palatine Tonsil / Q000821:virology; D011995:Recombination, Genetic; D013552:Swine; D014759:Viral Envelope Proteins / Q000502:physiology*; D014766:Viremia; D014774:Virulence; D037521:Virulence Factors / Q000502:physiology*
chemical_list: D014759:Viral Envelope Proteins; D037521:Virulence Factors; C087086:glycoprotein E2, classical swine fever virus
references.citation: Dtsch Tierarztl Wochenschr. 1999 Sep;106(9):394-7
references.pmid: 10547932
references.citation: Genome Res. 1999 Sep;9(9):868-77
references.pmid: 10508846
references.citation: J Virol. 2000 Apr;74(7):2973-80
references.pmid: 10708411
references.citation: Vet Microbiol. 2000 Jun 12;74(4):293-308
references.pmid: 10831853
references.citation: J Virol. 2000 Oct;74(20):9553-61
references.pmid: 11000226
references.citation: Vaccine. 2000 Oct 15;19(4-5):447-59
references.pmid: 11027808
references.citation: Virus Genes. 2001;23(1):63-8
references.pmid: 11556403
references.citation: J Virol. 2001 Oct;75(20):9585-95
references.pmid: 11559790
references.citation: Vaccine. 2002 Feb 22;20(11-12):1544-56
references.pmid: 11858861
references.citation: J Virol. 2002 Aug;76(16):8494-503
references.pmid: 12134054
references.citation: J Clin Microbiol. 2003 Jan;41(1):500-5
references.pmid: 12517907
references.citation: Virology. 2003 Mar 15;307(2):255-65
references.pmid: 12667795
references.citation: J Gen Virol. 2003 May;84(Pt 5):1269-74
references.pmid: 12692293
references.citation: Vaccine. 2004 Jan 2;22(3-4):317-28
references.pmid: 14670312
references.citation: J Virol. 2004 Aug;78(16):8812-23
references.pmid: 15280489
references.citation: Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
references.pmid: 271968
references.citation: Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95
references.pmid: 6546423
references.citation: Dtsch Tierarztl Wochenschr. 1990 Feb;97(2):77-9
references.pmid: 2311534
references.citation: J Virol. 1990 Aug;64(8):3563-9
references.pmid: 2370675
references.citation: J Virol. 1991 May;65(5):2761-5
references.pmid: 1850051
references.citation: J Virol. 1991 Sep;65(9):4705-12
references.pmid: 1870198
references.citation: Vet Microbiol. 1991 Oct;29(2):101-8
references.pmid: 1660637
references.citation: Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2002-6
references.pmid: 1549558
references.citation: J Virol. 1993 Sep;67(9):5435-42
references.pmid: 8350404
references.citation: Biochemistry. 1994 Mar 15;33(10):3038-49
references.pmid: 8130217
references.citation: J Virol. 1994 Jun;68(6):3934-42
references.pmid: 7514680
references.citation: J Virol. 1995 Oct;69(10):6479-86
references.pmid: 7666549
references.citation: J Clin Microbiol. 1996 Sep;34(9):2280-6
references.pmid: 8862599
references.citation: J Virol. 1996 Dec;70(12):8865-71
references.pmid: 8971015
references.citation: Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
references.pmid: 9254694
references.citation: J Gen Virol. 1997 Nov;78 ( Pt 11):2779-87
references.pmid: 9367363
references.citation: Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
references.pmid: 9396791
references.citation: J Virol. 1998 Jan;72(1):151-7
references.pmid: 9420210
references.citation: J Virol. 1998 Sep;72(9):7681-4
references.pmid: 9696875
references.citation: J Gen Virol. 1999 May;80 ( Pt 5):1157-65
references.pmid: 10355762
references.citation: J Mol Biol. 1999 Sep 17;292(2):195-202
references.pmid: 10493868
references.citation: J Virol. 1999 Dec;73(12):10224-35
references.pmid: 10559339